Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-05-25
1997-11-25
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530317, 530322, A61K 3810, C07K 500
Patent
active
056913044
ABSTRACT:
An improved process for producing a water-soluble polymyxin B/dextran conjugate comprises the step of reacting polymyxin B or pharmaceutically acceptable salt thereof with dextran in an aqueous media at a pH of about 9.3 to 10.
REFERENCES:
patent: 5177059 (1993-01-01), Handley et al.
Biotechnology Therapeutics, "Inhibition of Polysaccharide-Induced TNF-Alpha Production by Semisynthetic Polymyxin-B Conjugated Dextran", vol. 5, No. 3-4, 1994-1995, pp. 137-162, XP002015878, Coyne, C.P., et al.
Kapa Prasad
Kardash Gleb
Kucerovy Andrew
Lake Philip
Mattner Paul G.
Battle Carl W.
Gupta Anish
Loeschorn Carol A.
Novartis AG
Tsang Cecilia J.
LandOfFree
Improved process for preparing polymyxin B/dextran conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Improved process for preparing polymyxin B/dextran conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved process for preparing polymyxin B/dextran conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2107116